New eczema drug shows promise in Mid-Stage trial
Disease control
Recruiting now
This study tests an experimental drug called IMG-007 for adults with moderate-to-severe eczema (atopic dermatitis) that hasn't responded well to topical treatments. About 220 participants will receive either IMG-007 or a placebo to see if the drug safely reduces skin symptoms lik…
Phase: PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated May 11, 2026 20:39 UTC